HIV molecular immunology database

Search CTL/CD8+ T-Cell Epitope Database

HIV protein

HXB2 protein location

—

HXB2 DNA location

—

Results overlap with query location

Vaccine details
if Immunogen is Vaccine

Vaccine type
Vaccine strain
Vaccine component
Adjuvant

First Last

Click for Search Help

Search CTL/CD8+ variants

Questions or comments? Contact us at immuno@lanl.gov

- ALL -
Gag
p17
p24
p2p7p1p6
Gag/Pol
Pol
Gag/Pol-TF
Protease
RT
Integrase
Vif
Vpr
Tat
Rev
Vpu
gp160
Env
Nef
Cryptic
HIV-1
- NULL -
gp120
gp41

- ALL -
computer prediction
engineered
HIV-1 and HCV co-infection
HIV-1 exposed seronegative
HIV-1 infected monocyte-derived
HIV-1 infection
HIV-1 or HIV-2 infection
HIV-2 infection
in vitro stimulation or selection
peptide-HLA interaction
SHIV infection
SIV infection
vaccine
virus

- ALL -
A*01
A*01:01
A*01:23
A*02
A*02:01
A*02:02
A*02:05
A*02:06
A*02:07
A*02:14
A*02:17
A*03
A*03:01
A03 supertype
A1
A*11
A11
A*11:01
A*11:03
A11.1
A19
A2
A2.1
A*23
A23
A*23:01
A*24
A24
A*24:02
A*25
A25
A*25:01
A*26
A26
A*26:01
A*26:02
A*26:03
A*26:38
A28
A28 supertype
A*29
A29
A*29:02
A2 supertype
A3
A*30
A30
A*30:01
A*30:02
A*31
A31
A*31:01
A*32
A32
A*32:01
A*33
A33
A*33:01
A*33:03
A*34
A*34:02
A*36
A3 supertype
A*43:01
A*66
A*68
A68
A*68:01
A*68:02
A68 supertype
A*69
A*74
A74
A*74:01
A*80
A*80:01
B*07
B*07:02
B*07:05
B*08
B*08:01
B12
B*13
B13
B*13:02
B*14
B14
B*14:01
B*14:02
B*14:03
B*15
B15
B*15:01
B*15:02
B*15:03
B*15:10
B*15:16
B*15:17
B*15:24
B*15:40
B17
B*18
B18
B*18:01
B*27
B27
B*27:02
B*27:03
B*27:05
B*35
B35
B*35:01
B*35:02
B*35:03
B*35:05
B*35:08
B*37
B37
B*37:01
B*38
B38
B*38:01
B*39
B39
B*39:01
B*39:10
B*40
B40
B*40:01
B*40:02
B*40:06
B*41
B*42
B42
B*42:01
B*42:02
B*44
B44
B*44:02
B*44:03
B*44:15
B*45
B45
B*45:01
B*48:01
B*49
B49
B*49:01
B5
B*50
B50
B*50:01
B*51
B51
B*51:01
B*52
B52
B*52:01
B*53
B53
B*53:01
B*54
B*54:01
B*55
B55
B*55:01
B56
B*57
B57
B*57:01
B*57:02
B*57:03
B*58
B58
B*58:01
B*58:02
B*60
B60
B*61
B61
B*62
B62
B*63
B63
B*67:01
B*68
B7
B*70
B70
B71
B*73
B*78
B7 supertype
B8
B*81
B81
B*81:01
B*82
C*01
C*01:02
C*02
C*02:02
C*03
C*03:03
C*03:04
C*04
C*04:01
C*04:07
C*05
C*05:01
C*06
C*06:02
C*07
C*07:01
C*07:02
C*07:04
C*08
C*08:01
C*08:02
C*08:04
C*12
C*12:02
C*12:03
C*14
C*14:02
C*14:03
C*15
C*15:05
C*16
C*17
C*17:01
C*18
C*18:01
Cw1
Cw2
Cw3
Cw4
Cw5
Cw6
Cw7
Cw8
DPw4.2
DR1
DR4
DRA
E*01:01
E*01:03
H-2d
H-2D
H-2Db
H2-Dd
H-2Dd
H-2Dp
H-2Dq
H-2Kd
H-2Kk
H-2Ld
H-2a
H-2b
H-2bxd
H-2d17
H-2d
H-2f
H-2kd
H-2k
H-2p
H-2q
H-2u
Mamu A*01
Mamu-A*01
Mamu-A1*043:01
Mamu A1*065:01
Mamu-A*11
Mamu A*90120-5
Mamu-B*03
Mamu-B*04
Mamu B*08
Mamu B*17
Mamu-B*17
Mane A*10
Patr-B*02
Patr-B*03
Patr-B*14

- ALL -
acute/early infection
adjuvant comparison
antagonism
antibody binding site
antibody generation
assay or method development
autologous responses
binding affinity
bispecific/trispecific
broad neutralizer
CD4+ CTL
cell-line isolated antibody
characterizing CD8+ T cells
chronic infection
class I down-regulation by Nef
compensatory mutation
computational epitope prediction
contact residues
co-receptor
cryptic epitope
dendritic cells
drug resistance
dynamics
early-expressed proteins
early treatment
elite controllers
enhancing activity
epitope processing
escape
genital and mucosal immunity
HAART, ART
HIV-2
HIV exposed persistently seronegative (HEPS)
HIV reservoir/latency
HLA associated polymorphism
HLA cross-presentation
immunodominance
immunomodulation
immunotherapy
junction or synthetic peptide
kinetics
memory cells
mimotopes
mother-to-infant transmission
mutation acquisition
naive T cells
Nef-mediated down-regulation
neutralization by CTL
NK cells
non-susceptible form
novel epitope
optimal epitope
protective allele
rate of progression
responses in children
review
SIV
structure
subtype comparisons
superinfection
supertype
supervised treatment interruptions (STI)
T-cell crossreactivity to human proteins
TCR usage
Th1
Th2
therapeutic vaccine
transmission pair
vaccine antigen design
vaccine-induced immune responses
variant cross-reactivity
viral fitness and reversion
viral replication